Which has stronger earnings & valuation, CERT or WAY?

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.99 -$1.60M -$0.45 N/A Waystar $1.10B 4.23 $112.09M $0.70 34.61

Is CERT or WAY more profitable?

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Waystar 11.18% 7.03% 4.75%

Does the media refer more to CERT or WAY?

In the previous week, Certara had 23 more articles in the media than Waystar. MarketBeat recorded 25 mentions for Certara and 2 mentions for Waystar. Waystar's average media sentiment score of 1.34 beat Certara's score of 0.61 indicating that Waystar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 12 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, CERT or DOCS?

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.99 -$1.60M -$0.45 N/A Doximity $644.86M 7.76 $196.05M $0.85 32.18

Is CERT or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Doximity 25.48% 18.06% 15.40%

Does the media refer more to CERT or DOCS?

In the previous week, Doximity had 20 more articles in the media than Certara. MarketBeat recorded 45 mentions for Doximity and 25 mentions for Certara. Certara's average media sentiment score of 0.61 beat Doximity's score of 0.57 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 12 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 14 Very Positive mention(s) 4 Positive mention(s) 20 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, CERT or HTFL?

Certara has higher revenue and earnings than Heartflow. Certara is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.99 -$1.60M -$0.45 N/A Heartflow $176.03M 14.12 -$116.79M -$3.11 N/A

Is CERT or HTFL more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -58.42%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Heartflow -58.42% N/A -20.02%

Does the media prefer CERT or HTFL?

In the previous week, Certara had 24 more articles in the media than Heartflow. MarketBeat recorded 25 mentions for Certara and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Certara's score of 0.61 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 12 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is TDOC or CERT more profitable?

Teladoc Health has a net margin of -7.13% compared to Certara's net margin of -16.75%. Certara's return on equity of 3.86% beat Teladoc Health's return on equity. Company Net Margins Return on Equity Return on Assets Teladoc Health -7.13% -12.15% -5.83% Certara -16.75% 3.86% 2.65%

Does the media prefer TDOC or CERT?

In the previous week, Certara had 5 more articles in the media than Teladoc Health. MarketBeat recorded 25 mentions for Certara and 20 mentions for Teladoc Health. Certara's average media sentiment score of 0.61 beat Teladoc Health's score of 0.11 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 4 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Neutral Certara 12 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, SDGR or CERT?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.24 -$103.26M -$0.74 N/A Certara $418.84M 2.99 -$1.60M -$0.45 N/A

Is SDGR or CERT more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Certara -16.75% 3.86% 2.65%

Does the media prefer SDGR or CERT?

In the previous week, Certara had 9 more articles in the media than Schrodinger. MarketBeat recorded 25 mentions for Certara and 16 mentions for Schrodinger. Certara's average media sentiment score of 0.61 beat Schrodinger's score of 0.57 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Certara 12 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Certara (CERT) Competitors

$8.20 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$8.29 +0.09 (+1.10%)

As of 08/7/2026 07:34 PM Eastern

Compare

CERT vs. WAY, DOCS, HTFL, TDOC, and SDGR

Should you buy Certara stock or one of its competitors? MarketBeat compares Certara with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Certara include Waystar (WAY), Doximity (DOCS), Heartflow (HTFL), Teladoc Health (TDOC), and Schrodinger (SDGR). These companies are all part of the "healthcare technology" industry.

How does Certara compare to Waystar?

Certara (NASDAQ:CERT) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Certara had 23 more articles in the media than Waystar. MarketBeat recorded 25 mentions for Certara and 2 mentions for Waystar. Waystar's average media sentiment score of 1.34 beat Certara's score of 0.61 indicating that Waystar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	12 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market. Comparatively, Waystar has a beta of 0.06, suggesting that its stock price is 94% less volatile than the broader market.

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.99	-$1.60M	-$0.45	N/A
Waystar	$1.10B	4.23	$112.09M	$0.70	34.61

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Waystar	11.18%	7.03%	4.75%

Certara presently has a consensus price target of $8.28, indicating a potential upside of 0.95%. Waystar has a consensus price target of $35.23, indicating a potential upside of 45.39%. Given Waystar's stronger consensus rating and higher probable upside, analysts clearly believe Waystar is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Waystar	1 Sell rating(s)	2 Hold rating(s)	18 Buy rating(s)	3 Strong Buy rating(s)	2.96

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 3.5% of Waystar shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Waystar beats Certara on 14 of the 17 factors compared between the two stocks.

How does Certara compare to Doximity?

Certara (NASDAQ:CERT) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

Certara has a beta of 1.44, meaning that its share price is 44% more volatile than the broader market. Comparatively, Doximity has a beta of 1.29, meaning that its share price is 29% more volatile than the broader market.

74.0% of Certara shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 1.1% of Certara shares are owned by insiders. Comparatively, 31.8% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.99	-$1.60M	-$0.45	N/A
Doximity	$644.86M	7.76	$196.05M	$0.85	32.18

In the previous week, Doximity had 20 more articles in the media than Certara. MarketBeat recorded 45 mentions for Doximity and 25 mentions for Certara. Certara's average media sentiment score of 0.61 beat Doximity's score of 0.57 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	12 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	14 Very Positive mention(s)	4 Positive mention(s)	20 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara presently has a consensus target price of $8.28, suggesting a potential upside of 0.95%. Doximity has a consensus target price of $31.86, suggesting a potential upside of 16.48%. Given Doximity's higher probable upside, analysts plainly believe Doximity is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Doximity	3 Sell rating(s)	13 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.29

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Doximity	25.48%	18.06%	15.40%

Summary

Doximity beats Certara on 14 of the 17 factors compared between the two stocks.

How does Certara compare to Heartflow?

Certara (NASDAQ:CERT) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Certara presently has a consensus target price of $8.28, suggesting a potential upside of 0.95%. Heartflow has a consensus target price of $36.57, suggesting a potential upside of 26.90%. Given Heartflow's stronger consensus rating and higher probable upside, analysts plainly believe Heartflow is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Certara had 24 more articles in the media than Heartflow. MarketBeat recorded 25 mentions for Certara and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Certara's score of 0.61 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	12 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 7.7% of Heartflow shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Certara has higher revenue and earnings than Heartflow. Certara is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.99	-$1.60M	-$0.45	N/A
Heartflow	$176.03M	14.12	-$116.79M	-$3.11	N/A

Certara has a net margin of -16.75% compared to Heartflow's net margin of -58.42%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Heartflow	-58.42%	N/A	-20.02%

Summary

Certara beats Heartflow on 8 of the 15 factors compared between the two stocks.

How does Certara compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Teladoc Health has a net margin of -7.13% compared to Certara's net margin of -16.75%. Certara's return on equity of 3.86% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
Certara	-16.75%	3.86%	2.65%

Teladoc Health presently has a consensus price target of $7.54, suggesting a potential upside of 5.91%. Certara has a consensus price target of $8.28, suggesting a potential upside of 0.95%. Given Teladoc Health's higher probable upside, analysts plainly believe Teladoc Health is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Teladoc Health has a beta of 2.12, meaning that its stock price is 112% more volatile than the broader market. Comparatively, Certara has a beta of 1.44, meaning that its stock price is 44% more volatile than the broader market.

Certara has lower revenue, but higher earnings than Teladoc Health. Certara is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.51	-$200.32M	-$0.99	N/A
Certara	$418.84M	2.99	-$1.60M	-$0.45	N/A

In the previous week, Certara had 5 more articles in the media than Teladoc Health. MarketBeat recorded 25 mentions for Certara and 20 mentions for Teladoc Health. Certara's average media sentiment score of 0.61 beat Teladoc Health's score of 0.11 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	4 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	4 Negative mention(s)	2 Very Negative mention(s)	Neutral
Certara	12 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Certara beats Teladoc Health on 10 of the 17 factors compared between the two stocks.

How does Certara compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.24	-$103.26M	-$0.74	N/A
Certara	$418.84M	2.99	-$1.60M	-$0.45	N/A

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 1.1% of Certara shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Certara had 9 more articles in the media than Schrodinger. MarketBeat recorded 25 mentions for Certara and 16 mentions for Schrodinger. Certara's average media sentiment score of 0.61 beat Schrodinger's score of 0.57 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	12 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger presently has a consensus target price of $20.25, indicating a potential upside of 11.51%. Certara has a consensus target price of $8.28, indicating a potential upside of 0.95%. Given Schrodinger's higher possible upside, equities research analysts clearly believe Schrodinger is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Schrodinger has a beta of 1.63, meaning that its share price is 63% more volatile than the broader market. Comparatively, Certara has a beta of 1.44, meaning that its share price is 44% more volatile than the broader market.

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Certara	-16.75%	3.86%	2.65%

Summary

Certara beats Schrodinger on 11 of the 16 factors compared between the two stocks.

Get Certara News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CERT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CERT vs. The Competition

Export

Metric	Certara	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.25B	$1.52B	$7.00B	$12.99B
Dividend Yield	N/A	4.71%	2.58%	10.20%
P/E Ratio	-18.22	23.91	270.59	25.05
Price / Sales	2.99	67.94	599.45	84.15
Price / Cash	10.84	30.51	28.89	37.44
Price / Book	1.23	5.10	11.21	6.43
Net Income	-$1.60M	-$25.90M	$3.45B	$348.10M
7 Day Performance	0.24%	6.09%	3.41%	2.68%
1 Month Performance	21.12%	1.92%	-0.71%	-0.83%
1 Year Performance	-25.05%	-17.17%	77.31%	23.97%

Certara Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CERT Certara	1.9504 of 5 stars	$8.20 flat	$8.28 +0.9%	-25.0%	$1.25B	$418.84M	N/A	1,576	Earnings Report Gap Down
WAY Waystar	4.5098 of 5 stars	$22.66 +7.3%	$35.14 +55.1%	-30.0%	$4.05B	$1.10B	32.37	1,700	Positive News Analyst Forecast
DOCS Doximity	3.7792 of 5 stars	$21.72 +3.9%	$29.33 +35.0%	N/A	$3.82B	$644.86M	21.94	890	Trending News Earnings Report Analyst Forecast Gap Up
HTFL Heartflow	3.2613 of 5 stars	$26.76 +6.1%	$36.57 +36.7%	N/A	$2.18B	$176.03M	N/A	699	Positive News Analyst Upgrade Gap Down
TDOC Teladoc Health	1.6875 of 5 stars	$6.66 -0.8%	$7.54 +13.2%	+2.1%	$1.22B	$2.53B	N/A	5,600

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CERT) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Certara (CERT) Competitors